rp 73401 has been researched along with Pulmonary Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bednorz, M; Ghofrani, HA; Grimminger, F; Parajuli, N; Pichl, A; Schermuly, RT; Seeger, W; Seimetz, M; Weissmann, N | 1 |
de Visser, YP; Laghmani, el H; Middeldorp, M; Steendijk, P; van der Laarse, A; Wagenaar, GT; Walther, FJ | 1 |
2 other study(ies) available for rp 73401 and Pulmonary Hypertension
Article | Year |
---|---|
Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
Topics: Animals; Benzamides; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Hypertension, Pulmonary; Lung; Lung Compliance; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyridines; Smoke; Smoking; Tadalafil | 2015 |
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
Topics: Animals; Animals, Newborn; Benzamides; Bronchopulmonary Dysplasia; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Heart; Heart Injuries; Humans; Hyperoxia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infant, Newborn; Lung; Oxidative Stress; Oxygen; Phosphodiesterase 4 Inhibitors; Pulmonary Alveoli; Pyridines; Rats | 2012 |